The distribution and dosimetry of 111-IN-bleomycin in man.
The distribution of 111-In in the human body was studied after the injection of -111-In-bleomycin for tumour localization. Uptake in body organs was measured by quantitative scanning using a dual detector scanner. The estimated absorbed dose from an injection of 1 mCi was 0.3 rad to the whole body, and approximately 1 rad to bone marrow, kidneys, liver and spleen.
D001761:Bleomycin / Q000378:metabolism*; D001853:Bone Marrow / Q000378:metabolism; D006801:Humans; D007204:Indium / Q000378:metabolism*; D007668:Kidney / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D008657:Metabolic Clearance Rate; D011829:Radiation Dosage; D011868:Radioisotopes; D011877:Radionuclide Imaging; D013154:Spleen / Q000378:metabolism
D011868:Radioisotopes; D007204:Indium; D001761:Bleomycin